The FDA has accused pharmaceutical company Bristol Myers Squibb of making false or misleading claims about one of the company’s cancer drug, Krazati.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA calls out Bristol Myers over cancer drug claims
